Filing Details
- Accession Number:
- 0001415889-24-012874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-10 16:30:33
- Reporting Period:
- 2024-05-08
- Accepted Time:
- 2024-05-10 16:30:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-08 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-08 | 839 | $261.33 | 2,891 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 1,430 | $262.38 | 1,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 223 | $263.10 | 1,238 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 713 | $264.75 | 525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 113 | $266.10 | 412 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 253 | $266.58 | 159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 29 | $268.30 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-05-09 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-09 | 247 | $261.83 | 3,483 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-09 | 1,006 | $262.79 | 2,477 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-09 | 562 | $263.98 | 1,915 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-09 | 1,103 | $265.21 | 812 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-09 | 682 | $265.82 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-05-08 | 3,600 | $0.00 | 3,600 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-05-09 | 3,600 | $0.00 | 3,600 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 266,669 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 263,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $260.85 to $261.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $261.93 to $262.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $263.06 to $263.975. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $264.21 to $265.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $265.265 to $266.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $266.38 to $266.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $261.215 to $262.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $262.35 to $263.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $263.44 to $264.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $264.50 to $265.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $265.50 to $266.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
